Saphenous vein graft interventions

Emmanouil S. Brilakis, Michael Lee, Julinda Mehilli, Konstantinos Marmagkiolis, Josep Rodes-Cabau, Rajesh Sachdeva, Anna Kotsia, George Christopoulos, Bavana V. Rangan, Atif Mohammed, Subhash Banerjee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6% of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.

Original languageEnglish (US)
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume16
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Saphenous Vein
Percutaneous Coronary Intervention
Transplants
Coronary Vessels
Embolic Protection Devices
Drug-Eluting Stents
Stents

Keywords

  • Drug eluting stent
  • Internal mammary artery
  • Outcomes
  • Percutaneous coronary intervention
  • Saphenous vein grafts

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Saphenous vein graft interventions. / Brilakis, Emmanouil S.; Lee, Michael; Mehilli, Julinda; Marmagkiolis, Konstantinos; Rodes-Cabau, Josep; Sachdeva, Rajesh; Kotsia, Anna; Christopoulos, George; Rangan, Bavana V.; Mohammed, Atif; Banerjee, Subhash.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 16, No. 5, 2014.

Research output: Contribution to journalArticle

Brilakis, ES, Lee, M, Mehilli, J, Marmagkiolis, K, Rodes-Cabau, J, Sachdeva, R, Kotsia, A, Christopoulos, G, Rangan, BV, Mohammed, A & Banerjee, S 2014, 'Saphenous vein graft interventions', Current Treatment Options in Cardiovascular Medicine, vol. 16, no. 5. https://doi.org/10.1007/s11936-014-0301-x
Brilakis, Emmanouil S. ; Lee, Michael ; Mehilli, Julinda ; Marmagkiolis, Konstantinos ; Rodes-Cabau, Josep ; Sachdeva, Rajesh ; Kotsia, Anna ; Christopoulos, George ; Rangan, Bavana V. ; Mohammed, Atif ; Banerjee, Subhash. / Saphenous vein graft interventions. In: Current Treatment Options in Cardiovascular Medicine. 2014 ; Vol. 16, No. 5.
@article{8965cbe492a846f0866442ec7c5ae642,
title = "Saphenous vein graft interventions",
abstract = "Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6{\%} of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.",
keywords = "Drug eluting stent, Internal mammary artery, Outcomes, Percutaneous coronary intervention, Saphenous vein grafts",
author = "Brilakis, {Emmanouil S.} and Michael Lee and Julinda Mehilli and Konstantinos Marmagkiolis and Josep Rodes-Cabau and Rajesh Sachdeva and Anna Kotsia and George Christopoulos and Rangan, {Bavana V.} and Atif Mohammed and Subhash Banerjee",
year = "2014",
doi = "10.1007/s11936-014-0301-x",
language = "English (US)",
volume = "16",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Saphenous vein graft interventions

AU - Brilakis, Emmanouil S.

AU - Lee, Michael

AU - Mehilli, Julinda

AU - Marmagkiolis, Konstantinos

AU - Rodes-Cabau, Josep

AU - Sachdeva, Rajesh

AU - Kotsia, Anna

AU - Christopoulos, George

AU - Rangan, Bavana V.

AU - Mohammed, Atif

AU - Banerjee, Subhash

PY - 2014

Y1 - 2014

N2 - Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6% of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.

AB - Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6% of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.

KW - Drug eluting stent

KW - Internal mammary artery

KW - Outcomes

KW - Percutaneous coronary intervention

KW - Saphenous vein grafts

UR - http://www.scopus.com/inward/record.url?scp=84898791888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898791888&partnerID=8YFLogxK

U2 - 10.1007/s11936-014-0301-x

DO - 10.1007/s11936-014-0301-x

M3 - Article

C2 - 24643432

AN - SCOPUS:84898791888

VL - 16

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 5

ER -